News

Amgen plans to proceed with Phase 3 trials, initiating patients on a lower dosage that will gradually increase over an ...
Zacks Investment Research on MSN9h
Here's Why Amgen (AMGN) is a Strong Growth Stock
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both. The research service ...
The Amgen stock price suffered a harsh reversal in the fourth quarter of 2024 as its weight loss drug failed to excite. After peaking at $341 in July, the stock plunged by over 25% to the current ...
Our dashboard How Low Can Amgen Stock Go In A Market Crash? dives into historical performance across market crashes. Inflation Shock (2022) AMGN dropped 26.7% from $292.39 (8 Nov 2022) to $214.27 ...
Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether ...
Access Amgen stock price history with daily data, historical prices, all-time highs, and stock chart history. Download and analyze trends easily.
View the latest Amgen Inc. (AMGN) stock price, news, historical charts, analyst ratings and financial information from WSJ.
Investing.com - BMO Capital maintained its Outperform rating and $346.00 price target on Amgen (NASDAQ: AMGN) stock Tuesday following the release of Phase 1 MariTide clinical trial data.According ...
On May 1, Amgen reported a solid set of quarterly results. Q1 non-GAAP EPS of $4.90 topped the Wall Street consensus forecast by $0.64, while $8.1 billion of revenue, a 9% YoY increase, was a ...
View the latest Amgen Inc. (AMGN) stock price, news, historical charts, analyst ratings and financial information from WSJ.